These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1103 related items for PubMed ID: 30711707

  • 1. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X, Wang Z, Klaunig JE.
    Toxicology; 2019 Mar 15; 416():1-14. PubMed ID: 30711707
    [Abstract] [Full Text] [Related]

  • 2. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
    Su S, Billy LJ, Chang S, Gonzalez FJ, Patterson AD, Peters JM.
    Toxicology; 2022 Jan 15; 465():153056. PubMed ID: 34861291
    [Abstract] [Full Text] [Related]

  • 3. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
    Li X, Wang Z, Klaunig JE.
    Toxicology; 2018 Dec 01; 410():199-213. PubMed ID: 30120929
    [Abstract] [Full Text] [Related]

  • 4. High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways.
    Tan X, Xie G, Sun X, Li Q, Zhong W, Qiao P, Sun X, Jia W, Zhou Z.
    PLoS One; 2013 Dec 01; 8(4):e61409. PubMed ID: 23626681
    [Abstract] [Full Text] [Related]

  • 5. Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.
    Schlezinger JJ, Puckett H, Oliver J, Nielsen G, Heiger-Bernays W, Webster TF.
    Toxicol Appl Pharmacol; 2020 Oct 15; 405():115204. PubMed ID: 32822737
    [Abstract] [Full Text] [Related]

  • 6. Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors.
    Cheng X, Klaassen CD.
    Toxicol Sci; 2008 Nov 15; 106(1):29-36. PubMed ID: 18648086
    [Abstract] [Full Text] [Related]

  • 7. Synergistic Steatosis Induction in Mice: Exploring the Interactions and Underlying Mechanisms between PFOA and Tributyltin.
    Dauwe Y, Mary L, Oliviero F, Dubois L, Rousseau-Bacquie E, Gomez J, Gayrard V, Mselli-Lakhal L.
    Cells; 2024 May 30; 13(11):. PubMed ID: 38891072
    [Abstract] [Full Text] [Related]

  • 8. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H, Ahn J, Shin SS, Yoon M.
    Int J Obes (Lond); 2019 Aug 30; 43(8):1620-1630. PubMed ID: 30283077
    [Abstract] [Full Text] [Related]

  • 9. Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.
    Cheng X, Klaassen CD.
    Toxicol Sci; 2008 Nov 30; 106(1):37-45. PubMed ID: 18703564
    [Abstract] [Full Text] [Related]

  • 10. Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid.
    Abe T, Takahashi M, Kano M, Amaike Y, Ishii C, Maeda K, Kudoh Y, Morishita T, Hosaka T, Sasaki T, Kodama S, Matsuzawa A, Kojima H, Yoshinari K.
    Arch Toxicol; 2017 Jun 30; 91(6):2365-2374. PubMed ID: 27832320
    [Abstract] [Full Text] [Related]

  • 11. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R, Yu Y, Hu S, Zhang J, Yang H, Han B, Cheng Y, Luo X.
    Nutr Res; 2016 Sep 30; 36(9):1022-1030. PubMed ID: 27632923
    [Abstract] [Full Text] [Related]

  • 12. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q, Zeng J, Yao K, Wang W, Wu Q, Tang R, Xia X, Zou X.
    Biochem Biophys Res Commun; 2020 Nov 12; 532(3):362-369. PubMed ID: 32883523
    [Abstract] [Full Text] [Related]

  • 13. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.
    Yang Q, Shu F, Gong J, Ding P, Cheng R, Li J, Tong R, Ding L, Sun H, Huang W, Wang Z, Yang L.
    J Ethnopharmacol; 2020 Jun 12; 255():112556. PubMed ID: 31926984
    [Abstract] [Full Text] [Related]

  • 14. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z, Li S, Wang R, Guo L, Xu D, Zhang T, Xu Y, Wang W, Wang M, Gan Z, Wang X.
    Mol Med; 2020 Jun 05; 26(1):54. PubMed ID: 32503411
    [Abstract] [Full Text] [Related]

  • 15. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.
    Wahlang B, Falkner KC, Gregory B, Ansert D, Young D, Conklin DJ, Bhatnagar A, McClain CJ, Cave M.
    J Nutr Biochem; 2013 Sep 05; 24(9):1587-95. PubMed ID: 23618531
    [Abstract] [Full Text] [Related]

  • 16. Effects of Callistephus chinensis flower polyphones on improving metabolic disorders in high-fat diet-induced mice.
    Bi X, Liu W, Xia X, Chen L, Mu T, Liu J, Hou Y, Zhao Y.
    Food Funct; 2014 Dec 05; 5(12):3304-10. PubMed ID: 25367327
    [Abstract] [Full Text] [Related]

  • 17. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
    Han HY, Lee SK, Choi BK, Lee DR, Lee HJ, Kim TW.
    Biol Pharm Bull; 2019 Dec 05; 42(2):255-260. PubMed ID: 30713255
    [Abstract] [Full Text] [Related]

  • 18. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
    Liu M, Zhang G, Wu S, Song M, Wang J, Cai W, Mi S, Liu C.
    J Ethnopharmacol; 2020 Jun 12; 255():112776. PubMed ID: 32205261
    [Abstract] [Full Text] [Related]

  • 19. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R, Lu CK, Nguyen HM, Hsiao HH, Chen CJ, Hsiao HP, Lin KJ, Fang CC, Yen CH.
    Biomed Pharmacother; 2020 Sep 12; 129():110348. PubMed ID: 32554245
    [Abstract] [Full Text] [Related]

  • 20. Hepatic carboxylesterases are differentially regulated in PPARα-null mice treated with perfluorooctanoic acid.
    Wen X, Baker AA, Klaassen CD, Corton JC, Richardson JR, Aleksunes LM.
    Toxicology; 2019 Mar 15; 416():15-22. PubMed ID: 30685356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.